Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced ...

Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that early results of a subset of 60 real-world acute, subacute ...

The inability of QFR to rival FFR for 1-year MACE is a reminder of the need for large studies, even when new tech is enticing ...

These statements are based on our current beliefs using information available ... and data from the US ACURATE IDE will be presented at TCT on October 30. WATCHMAN grew 18% with continued ...

The heparin frequently given before percutaneous coronary intervention (PCI) should be pushed to as early as possible in ...

Its current drive is for increased transparency ... carpet tile and its Kinetex textile composite tile (TCT) for the education sector. First introduced two years ago, TCT won a Silver award ...

TCT 464: A Novel Approach to Treat and Reverse Moderate/Servere Heart Failure to NYHA I-II Using Direct Electrical Microcurrent Receive the the latest news, research, and presentations from major ...

The 2024 edition of Transcatheter Cardiovascular Therapeutics (TCT) once again highlighted significant innovations in ...

The ECLIPSE trial, presented as a late-breaking study at the Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics (TCT) conference in Washington, D.C., had enrolled ...

“You know, I give a lot of credit to, uh, President Zelensky, who has been on the front lines for three years,” Warren said during the Massachusetts Senate debate after she and Deaton were ...